Avoid These Peptides for 2026 (Doctor Reveals Peptides to Avoid)
A chiropractor who runs a peptide coaching clinic sorts peptides into 'avoid entirely' and 'use with caution' lists, giving his reasons for each in about 17 minutes.
With Dr. Jones, DC (DC)
Key moments
Tap a moment to play the video from there.
- 0:00Intro and the two tiersJones says some peptides are more dangerous than people realize and explains he will split them into avoid-entirely and use-with-caution lists.
- 1:32Patient who stacked five peptidesHe describes a patient who self-dosed a stack from research sites and developed bloating, worse glucose, mood swings and poor sleep. He blames the combination and lack of monitoring.
- 2:04Three ways peptides cause harmHe lays out bad molecules, bad sources and bad protocols, and says this video focuses on bad molecules.
- 2:50Oral BPC-157 bucketsJones separates supplement capsules, research-site products and clinic-directed oral BPC-157. He puts the first two on his avoid list and says even the third is not proven safe.
- 4:57CJC-1295 with and without DACHe explains that the DAC version lasts 6 to 8 days and cannot be titrated. He prefers the no-DAC version paired with ipamorelin.
- 7:38MK-677 and insulin resistanceJones says MK-677 acts on ghrelin receptors and, per clinical trials, raises insulin resistance and appetite. He notes it is not FDA approved.
- 9:40Hexarelin and GHRP stackingHe says hexarelin and related GHRPs raise cortisol and prolactin and lose effect within about a month. He warns about stacking several compounds at once.
- 11:43IGF-1 LR3 and cancer associationHe describes direct IGF-1 analogs as bypassing the body's own regulation. He cites population links to certain cancers while stressing they do not prove cause.
- 13:26Epitalon hype versus dataJones says the epitalon studies are small and mostly from one research group. He sees the main risk as wasting money.
- 14:14FOXO4-DR1 and zombie cellsHe explains senescent cells and says FOXO4-DR1 belongs in monitored trials because he is concerned about its selectivity.
What the video says
Dr. Jones, who says he coaches thousands of patients on peptide strategies, argues that some peptides are riskier than their reputation suggests. He splits them into two lists: tier 1, which he tells patients to avoid entirely, and tier 2, which he calls cautionary. He opens with a patient who, by his account, self-administered five peptides from research sites using doses taken from Reddit. Within three weeks the patient had bloating, worse fasting glucose, mood swings, poor sleep and low libido. Jones says the peptides were probably genuine and that the combination, with nobody monitoring, was the problem. He names three ways peptides can hurt people: bad molecules, bad sources and bad protocols. He says this video is about the first.
In tier 1 he puts oral BPC-157 bought as supplement capsules or research-site products, because he says no one verifies what is inside. He is positive about injectable BPC-157 from a legitimate source. He also lists CJC-1295 with DAC, which he says lasts 6 to 8 days and cannot be adjusted if side effects appear. He suggests that constant stimulation could make the pituitary less responsive. He prefers CJC-1295 without DAC paired with ipamorelin. He lists MK-677 as a small molecule rather than a peptide and says clinical trials show it raises insulin resistance and appetite. He adds that it is not FDA approved and is prohibited by the World Anti-Doping Agency. His last tier 1 item is hexarelin and stacks of GHRP-2, GHRP-6 and similar compounds. He says these raise cortisol and prolactin, lose effect within about a month, and are often combined with no data on interactions.
In tier 2 he covers IGF-1 LR3 and DES. He says population studies link high IGF-1 to certain cancers, that this is an association and not proven causation, and that he would not use them himself. He calls epitalon over-hyped, citing small studies with weak methods, and says its main risk is wasted money. He says FOXO4-DR1 belongs in monitored research trials because he worries about how selective it is.
The video also promotes his clinic's supervised programs and free discovery calls several times, which is worth keeping in mind when weighing his advice.
On each compound
BPC-1572:50
Jones says injectable BPC-157 from a legitimate source has almost no downside. He puts gray-market oral capsules and research-site oral products on his avoid list because of unverified contents, and notes there is no FDA approved oral version.
See how your DNA reads BPC-157CJC-12954:57
Jones says CJC-1295 with DAC lasts 6 to 8 days, cannot be adjusted if side effects appear, and may leave the pituitary less responsive. He prefers the short-acting no-DAC version combined with ipamorelin.
See how your DNA reads CJC-1295Ipamorelin6:36
Jones recommends ipamorelin paired with CJC-1295 without DAC as his preferred growth hormone option. He calls it more selective, with minimal cortisol and prolactin elevation.
See how your DNA reads IpamorelinHexarelin9:40
Jones calls hexarelin the most potent GHRP and says it gives large initial growth hormone spikes. He says its effects fade within about a month, that it needs 4 to 8 weeks off, and that it may raise cortisol, prolactin and water retention.
See how your DNA reads HexarelinGHRP-210:41
Jones groups GHRP-2 with the 'dirty' growth hormone releasers that he says come with metabolic side effects. He says the bigger danger is stacking it with other compounds.
See how your DNA reads GHRP-2GHRP-610:41
Jones places GHRP-6 in the same 'dirty' category as GHRP-2 and hexarelin. He describes it as growth hormone release plus unwanted metabolic effects.
See how your DNA reads GHRP-6IGF-1 LR311:43
Jones says IGF-1 LR3 and DES are direct IGF-1 analogs popular in bodybuilding. He says he would not touch them, noting population links between high IGF-1 and some cancers while stressing these are associations.
See how your DNA reads IGF-1 LR3Epithalon13:26
Jones says epitalon is marketed as activating telomerase but that the studies are small, with weak methods and mostly from one research group. He sees the main risk as wasted money.
See how your DNA reads Epithalon“Less chaotic is not the same as magic.”
“You can't turn it off when it's in there.”
What this video doesn’t settle
- The opening patient case is one anecdote told by the host, with no testing of what he took and no comparison group.
- Jones gives no citations on screen for the clinical trials, IGF-1 population studies or MK-677 findings he describes, so they cannot be checked from the video.
- His tier lists reflect his clinic's own judgment and preferred protocols, and the video repeatedly promotes the clinic's paid supervised programs.
Questions this video answers
Why does Dr. Jones say to avoid oral BPC-157?
He says supplement capsules and research-site products have no reliable third-party testing, so buyers cannot know what is in them. He distinguishes these from injectable BPC-157 from a legitimate source, which he says has almost no downside.
What is the problem with CJC-1295 with DAC according to this video?
Jones says the DAC version stays active for 6 to 8 days, so side effects like flushing, water retention or headaches cannot be adjusted away. He also worries that constant growth hormone stimulation may make the pituitary less responsive.
What does Dr. Jones say about MK-677?
He describes it as a small molecule that activates ghrelin receptors, not a peptide. He says clinical trials show it raises insulin resistance, and he reports appetite increase, water retention and bloating. He adds that it is not FDA approved and that WADA prohibits it.
Why does Jones recommend against stacking growth hormone peptides?
He says combining compounds like CJC-1295, hexarelin, GHRP-2 and MK-677 stacks overlapping side effects, with no data on how they interact. He ties this to his opening patient example.
What does Jones say about the cancer risk of IGF-1 analogs?
He says population studies link elevated IGF-1 to certain cancers, but that this is an association and genetic studies have been inconclusive. He also describes a U-shaped pattern in which both very low and very high levels are linked to higher risk.
Video by Dr. Jones, DC on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
